Maternal Mindfulness: Depression and Postpartum Pain
MaMiDaPP
Maternal Mindfulness to Prevent Depression and Reduce Postpartum Pain (MaMiDaPP) Intervention
1 other identifier
interventional
75
1 country
1
Brief Summary
This phase I clinical trial tests the feasibility and safety of a self-guided, mobile mindfulness-based intervention to reduce post-cesarean pain and prevent postpartum depression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 27, 2022
CompletedFirst Posted
Study publicly available on registry
June 1, 2022
CompletedStudy Start
First participant enrolled
December 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 31, 2028
August 6, 2026
August 1, 2026
2.3 years
May 27, 2022
August 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Post-operative pain
Numerical Pain Rating Scale (NPRS); Participant reported pain intensity (0 is equivalent to no pain and 10 indicates the worst possible pain) and pain unpleasantness (0 is equivalent to not at all unpleasant and 10 indicates the most unpleasant feeling possible)
1 week postpartum and 8 weeks postpartum
Secondary Outcomes (1)
Postpartum depression
1 week postpartum and 8 weeks postpartum
Study Arms (2)
Mindfulness
EXPERIMENTALReceiving mobile, self-guided mindfulness intervention
Treatment as usual with monitoring
NO INTERVENTIONReceiving treatment as usual with monitoring by study PI and investigators.
Interventions
Meditation training to help reduce stress and reactivity to pain and other stressors.
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- University of Illinois at Urbana-Champaignlead
- Southern Illinois Universitycollaborator
- Arrowhead Regional Medical Centercollaborator
- University of Utahcollaborator
Study Sites (1)
University of Illinois Urbana-Champaign
Champaign, Illinois, 61820, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 27, 2022
First Posted
June 1, 2022
Study Start
December 1, 2025
Primary Completion (Estimated)
March 31, 2028
Study Completion (Estimated)
March 31, 2028
Last Updated
August 6, 2026
Record last verified: 2026-08